Why is Eli Lilly stock surging today?
- Investing.com
- 1
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
OmniAb Inc (OABI)
OmniAb Inc stock price live, this page displays NASDAQ OABI stock exchange data. View the OABI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the OmniAb Inc real time stock price chart below.
What Is the OmniAb Inc Stock Price Today?
The OmniAb Inc stock price today is 4.385.
What Is the Stock Symbol for OmniAb Inc?
The stock ticker symbol for OmniAb Inc is OABI.
Is OABI the Same as $OABI?
$OABI is a common way to refer to the OmniAb Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does OmniAb Inc Trade On?
OmniAb Inc is listed and trades on the NASDAQ stock exchange.
Is OmniAb Inc a Good Stock to Buy?
Determining whether OmniAb Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current OmniAb Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OABI quote. (ISIN: US68218J1034)
What Is the OmniAb Inc Stock Price Today?
The OmniAb Inc stock price today is 4.385.
What Is the Stock Symbol for OmniAb Inc?
The stock ticker symbol for OmniAb Inc is OABI.
Is OABI the Same as $OABI?
$OABI is a common way to refer to the OmniAb Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does OmniAb Inc Trade On?
OmniAb Inc is listed and trades on the NASDAQ stock exchange.
Is OmniAb Inc a Good Stock to Buy?
Determining whether OmniAb Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current OmniAb Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OABI quote. (ISIN: US68218J1034)
NASDAQ
Currency in USD
4.370
+0.070(+1.63%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.140
4.535
52 wk Range
1.300
4.590
OABI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.1404.535
52 wk Range
1.3004.590
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OABI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
7.667
Upside
+75.44%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
Why is OmniAb stock surging today?- Investing.com
- Why is Eli Lilly stock surging today?
- Investing.com
- 1
- Why is OmniAb stock surging today?
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.667
(+75.44% Upside)
OmniAb Inc SWOT Analysis
Analyst Outlook | Learn about OmniAb's stock performance and analyst targets, with RBC Capital Markets setting price targets ranging from $4.00 to $8.00 |
Market Dynamics | Uncover OmniAb's competitive positioning in the antibody discovery market, balancing partner expansion with in-house capabilities of pharmaceutical companies |
Financial Landscape | Delve into OmniAb's revenue projections of $20-25 million for FY'25, with contracted potential milestones exceeding $550 million |
Antibody Innovation | Explore OmniAb's cutting-edge antibody discovery platforms and the recent launch of their Xploration instrument, enhancing their technological arsenal |
OmniAb Inc Earnings Call Summary for Q2/2026
- OmniAb Q2 revenue hit $13.41M, beating estimates by 171% and raising FY2026 guidance to $32M-$36M from prior outlook.
- Net loss narrowed to 5 cents/share vs. 15 cents year-ago; stock surged 15.8% on results, trading near 52-week high of $2.79.
- Company operates 425 active programs with 110 partners, including $3B+ milestone potential and 3.4% average royalty rate.
- New platforms OmniUltra and xPloration gaining partner traction; two instruments sold in Q2 diversifying revenue beyond milestones.
- Year-end cash projected at $37M-$41M with $15M annual burn; CFO signals operating leverage as revenue scales without expense growth.
Last Updated: 08/06/2026, 05:36 PM
Read Full TranscriptOmniAb investor slides for Q2/2026
Last Update: Aug 06, 2026
See full investor slides
Earnings
Latest Release
Aug 06, 2026
EPS / Forecast
-0.05 / -0.12
Revenue / Forecast
13.41M / 4.95M
Compare OABI to Peers and Sector
Metrics to compare | OABI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOABIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −14.4x | −16.0x | −0.3x | |
PEG Ratio | −0.33 | 0.01 | 0.00 | |
Price / Book | 2.4x | 5.5x | 2.6x | |
Price / LTM Sales | 16.6x | 11.1x | 3.1x | |
Upside (Analyst Target) | 86.0% | −2.2% | 47.6% | |
Fair Value Upside | Unlock | −17.3% | 5.6% | Unlock |
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company’s technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners’ drug development efforts. Its OmniAb platform’s Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company offers animal-based technologies include OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences; OmniFlic, a bispecific rat and OmniClic, a bispecific chicken are designed for discovery of bispecific antibody applications; OmniTaur, which provides cow-inspired antibodies with unique structural characteristics for challenging targets; OmnidAb, an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold; and OmniDeep, a suite of in silico, an artificial intelligence (AI) and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. It has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology to incorporate the STR technology into antibodies that have been generated using OmniAb’s antibody discovery platform. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the OmniAb (OABI) Stock Price Today?
The OmniAb stock price today is 4.370 USD.
What Stock Exchange Does OmniAb Trade On?
OmniAb is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for OmniAb?
The stock symbol for OmniAb is "OABI."
What Is the OmniAb Market Cap?
As of today, OmniAb market cap is 625.180M USD.
What Is OmniAb's Earnings Per Share (TTM)?
The OmniAb EPS (TTM) is -0.354.
When Is the Next OmniAb Earnings Date?
OmniAb will release its next earnings report on Nov 17, 2026.
From a Technical Analysis Perspective, Is OABI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has OmniAb Stock Split?
OmniAb has split 0 times.
How Many Employees Does OmniAb Have?
OmniAb has 89 employees.
What is the current trading status of OmniAb (OABI)?
As of Aug 21, 2026, OmniAb (OABI) is trading at a price of 4.370 USD, with a previous close of 4.300 USD. The stock has fluctuated within a day range of 4.140 USD to 4.535 USD, while its 52-week range spans from 1.300 USD to 4.590 USD.
What Is OmniAb (OABI) Price Target According to Analysts?
The average 12-month price target for OmniAb is 7.667 USD, with a high estimate of 11 USD and a low estimate of 4 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +75.44% Upside potential.
What Is the OABI Premarket Price?
OABI's last pre-market stock price is 4.340 USD. The pre-market share volume is 13,310.000, and the stock has decreased by 0.040, or 0.930%.
What Is the OABI After Hours Price?
OABI's last after hours stock price is 4.180 USD, the stock has decreased by -0.120, or -2.790%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.